Biotech & AI drug discoverySTAT — Biotech

STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down

Caribou Biosciences, a biotech co-founded by Jennifer Doudna, is shutting down after failing to raise the money necessary to fund a late-stage clinical trial of its off-the-shelf CAR-T therapy for lymphoma.

AI summary · generated only from source feed metadata; consult original

Source published2026-10-07T08:30:00+00:00

Published here2026-10-07T10:22:11+00:00

Original source

STAT — Biotech

Media report · consult original reporting

Read the original ↗https://www.statnews.com/2026/10/07/caribou-biosciences-shutting-down-lymphoma-car-t-therapy/

Original headline

STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.